Cedarbaum Presents on Current Research, Technological Advancements for Parkinson’s Disease
Jesse Cedarbaum, professor adjunct of neurology and psychiatry at Yale, presented in the American Parkinson Disease Association September webinar series, “Preventing Parkinson’s Disease: The Long and Winding Road that Leads to YOUR Door." Dr. Cedarbaum gave an overview of current and future research in Parkinson's disease, as well as developments in technology designed to manage syptoms in patients.
"Fitness Counts" Unites Parkinson’s Disease Researchers and Activists
The Yale Movement Disorders Division joined forces with the Parkinson’s Foundation at an event entitled “Fitness Counts” on October 14, 2022. The event featured remarks by Yale's Veronica Santini, Sule Tinaz, and Christine Gummerson, as well as Beat PD Today founder Michelle Hespeler.
Research Applies Machine Learning/AI to Predict Consciousness for Driving in People with Epilepsy
A new study published in September 2022 in Annals of Clinical and Translational Neurology may guide doctors in how to proceed when they observe SWDs on EEG, but are unclear of the patient’s neurological capacity for driving. Led by Principal Investigator Hal Blumenfeld, MD, PhD, researchers have harnessed the power of machine learning/artificial intelligence (AI) to address the shortcomings of traditional testing.
Testing assumptions about cardiovascular health in underrepresented groups
Julian Acosta, MD, Guido Falcone, MD and MD/MHS Student Audrey Leasure study the correlation between cardiovascular disease prevalence and populations underrepresented in medicine by using the All of Us dataset.Source: National Institutes of Health All of Us Research Program
Le Zhang, PhD Wins Avenir Award for Research on Substance Use Disorders and HIV/AIDS
Assistant Professor Le Zhang, PhD was recently awarded a DP2 grant from the National Institutes of Health (NIH), entitled “Immune Network Dysregulation of the Central Nervous System with HIV Persistence and Opioid Abuse.” The grant, which amounts to more than $2.5 million, began on May 15, 2022 and lasts for four years.
Long COVID and Cognitive Dysfunction: Searching for Answers
Gilbert H. Glaser professor of Neurology and chief of the Division of Neurological Infections and Global Neurology Serena Spudich, MD shares her knowledge of cognitive dysfunction in long-COVID patients, research conducted in her COVID Mind Study and Yale program, and what treatment options are currently available.Source: TheBodyPro
Natalia Szejko, MD, PhD Wins 2022 ESOC Young Research Investigator Award for Stroke Research
During the 2022 European Stroke Organisation Conference (ESOC) held from May 4-6, Natalia Szejko, MD, PhD a postdoctoral fellow in the Falcone Lab was awarded the ESOC Young Research Investigator Award in Stroke for her submitted abstract, “Epigenetic Age and Ischemic Stroke: Findings from the Health and Retirement Study.”
Philanthropist Nancy Davis Opens Up About Life with Multiple Sclerosis and Her Mission to Help Others
Philanthropist Nancy Davis tells her story of living with multiple sclerosis, from her diagnosis after a ski accident to how she eventually found the treatment plan that was right for her. Yale Neurology Chair David Hafler, MD also speaks about how far research into the autoimmune disease has come and what the most effective treatment strategies are.Source: People
Emily Gilmore, MD Joins the American Board of Clinical Neurophysiology
The American Board of Clinical Neurophysiology (ABCN) has invited associate professor Emily Gilmore, MD, to serve as board member, effective immediately. Dr. Gilmore will play a significant role in the ABCN examination development, including writing and editing questions.
Gianvito Masi, MD Named MGNet Scholar for Myasthenia Gravis Research
Gianvito Masi, MD, a neurologist in the lab of Kevin O’Connor, PhD, has been selected as a MGNet Scholar by the Myasthenia Gravis Rare Disease Network (MGNet), which is part of the National Institutes of Health’s Rare Diseases Clinical Research Network. The grant, “Investigating immune mechanisms underlying checkpoint inhibitor myasthenia gravis,” funds two years of research and will begin in June 2022.
Yale experts make strides in Multiple Sclerosis research
Yale School of Medicine researchers have furthered our understanding of the immune mechanisms of multiple sclerosis, discovered that B-cell depleting drugs reduce symptoms of inflammation in MS patients, and have made significant strides in earlier diagnoses.Source: Yale Daily News